American Cancer Society announces $20 million for Hope
Lodge Boston construction; $7 million from AstraZeneca is largest
single purpose gift in ACS history
The American Cancer Society, New England Division, today announced
that its campaign to build a Hope Lodge in Boston has received a
$7 million gift from AstraZeneca Pharmaceuticals LP, one of the
world’s leading pharmaceutical companies, to name the building at
125 South Huntington Avenue. When it is opened by the American
Cancer Society in spring 2008, the AstraZeneca Hope Lodge Center
in Boston will annually provide free lodging and support services
to more than 1,500 cancer outpatients and their caregivers who
must travel far from home for treatment in Boston.
This AstraZeneca contribution represents the largest single
gift restricted to one purpose or program in the 93-year history
of the American Cancer Society.
Since the Hope Lodge campaign began two and a half years ago, more
than $20 million has been raised by the volunteer Campaign
Cabinet. The American Cancer Society still needs to raise another
$5 million to complete the project. In 2004, the Dana-Farber
Cancer Institute invested $2.5 million in the project, followed in
2005 by gifts of $2 million each from Massachusetts General
Hospital and Brigham & Women’s Hospital, the founding hospitals of
Partners HealthCare. The combined investments of the three
hospitals enabled the American Cancer Society to purchase the site
of the former Vincent Memorial Hospital for the new Lodge.
Four gifts of $1 million or more, as well as numerous six-figure
gifts, have been received from individual philanthropists,
organizations, and foundations committed to increasing access to
state-of-the-art treatment for cancer patients living outside the
greater Boston area.
The new AstraZeneca Hope Lodge Center will provide 40 guest suites
in a supportive and home-like atmosphere for cancer patients and
their families during what is often a difficult and emotional
time. The AstraZeneca Hope Lodge Center will provide up to 14,600
free nights of housing each year. Currently, only 61 hospitality
rooms are available to cancer patients traveling to Boston for
medical treatment, while the number of patients needing such
support continues to rise.
“AstraZeneca has always displayed tremendous commitment to
patients, particularly cancer patients,” said David S. Rosenthal,
MD, co-chair of the volunteer Hope Lodge Boston Campaign Cabinet.
“Their generous gift to name the Boston Hope Lodge is yet another
example of their dedication to improving the quality of life of
cancer patients. Because of their generosity and vision, the
American Cancer Society will be able to begin providing lodging
and support nearly two years ahead of schedule to hundreds of
cancer patients coming for treatment in Boston, one of the
nation’s leading comprehensive cancer centers.”
With its U.S. headquarters in Wilmington, Delaware, AstraZeneca
has its second largest presence in Massachusetts, with a major
cancer research facility in Waltham and operations located in
Westborough. According to Tony Zook, President and CEO of
AstraZeneca U.S., the company’s naming of the Boston Hope Lodge is
“a living example of how important it is for AstraZeneca to
contribute to the communities in which we live and work.”
“Patients are at the center of everything we do at AstraZeneca,”
Mr. Zook said. “With a 30-year history of discovering and
developing some of the world’s leading oncology products,
AstraZeneca is committed to giving patients access to the
medicines and care they need to live longer, healthier lives. The
new AstraZeneca Hope Lodge Center in Boston will assure that more
patients can take advantage of the high-quality cancer care that
Boston offers.”
Situated close to Boston’s world-class medical institutions, the
50,000 square foot facility will be the third American Cancer
Society Hope Lodge in New England; the others are located in
Worcester, MA, and Burlington, VT. While the façade of the
historic 1907 building will be retained, work on the building will
begin this month, with the groundbreaking for the new building
expected in March 2007. Plans call for the AstraZeneca Hope Lodge
Center to be completed and serving patients by spring 2008.
“The American Cancer Society’s New England Division is deeply
grateful to AstraZeneca for their $7million gift, which will
surely make a meaningful difference in the lives of thousands of
cancer patients and their families,” said Don Gudaitis, CEO of the
New England Division of the American Cancer Society.
The American Cancer Society has opened 23 Hope Lodges throughout
the United States over the past 20 years, each providing free
temporary housing facilities for cancer patients undergoing
treatment far from their homes, as well as transportation,
counseling, and other vital support services. For more details,
contact Thomas P. Sellers, ACS Chief Financial Officer & Project
Manager for Hope Lodge Boston, at 508.270.4760.
The American Cancer Society is the nationwide community-based
voluntary health organization dedicated to eliminating cancer as a
major health problem by preventing cancer, saving lives and
diminishing suffering from cancer, through research, education,
advocacy and service. For information about cancer, call toll-free
anytime 1.800.ACS.2345 or visit the American Cancer Society at
www.cancer.org.
|